Individualized Physical Exercise Training and Enhanced Protein Intake in Older Citizens During Municipality-based Rehabilitation

June 22, 2023 updated by: Sanel Teljigovic, University College Absalon
The study will investigate if: 1) individualized physical exercise training in combination with extra protein intake can increase measures on all three ICF-levels? 2) extra protein intake alone increases outcomes of usual care treatment?

Study Overview

Detailed Description

Successful rehabilitation of the growing number of elderly citizens can lead to preservation of functional independence and improvement in the quality of life.

The aim of the study is to investigate the effect of an individually tailored physical exercise training program combined with increased protein intake in order to improve measures on all three ICF levels (International Classification of Functioning, Disability, and Health). By conducting the study in a real-life clinical setting, research is translated into practice involving health professionals and the target group in the development of new knowledge on how to enhance the outcome of rehabilitation, thereby increasing the overall capacity of the elderly citizen, and decreasing the expenditure of health-services.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Zealand
      • Slagelse, Zealand, Denmark, 4200
        • Sundhed og Træning

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

All citizens that are referred to the health/rehabilitation center age 65 years and older from Slagelse municipality will be invited to a screening interview with a physiotherapist after which the participant will be asked to join the study if not subject to one of the following exclusion criteria's:

Exclusion Criteria:

  • inability to speak or read Danish,
  • renal diseases,
  • active cancer,
  • upper or lower limp amputations,
  • milk/lactose allergy or intolerance,
  • hypertension >180/110,
  • pacemaker/other implanted electrical stimulants (due to Bio-Impedance Analysis),
  • progressive somatic or psychiatric diseases which can affect the course of training,
  • referred to rehabilitation primarily due to gynecological and neurological conditions (apoplexies) or surgeries where movement restrictions are recommended,
  • daily medication that may have an impact on muscle protein synthesis,
  • alcohol intake greater than 14 units per week,
  • discouragement from a general practitioner.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Usual Care
Usual care involves physiotherapeutic rehabilitation in an unknown format, and will, therefore, be monitored closely and described accordingly.
Usual care involves physiotherapeutic rehabilitation in an unknown format, and will, therefore, be monitored closely and described accordingly.
Experimental: Usual Care with Protein Supl.
Usual care involves physiotherapeutic rehabilitation in an unknown format, and will, therefore, be monitored closely and described accordingly.
The intake of protein supplementation (ARLA PROTINO) will be consumed by participants in the form of protein-enriched yogurts for easy consumption two times daily, with each bottle containing 14 g of protein.
Other Names:
  • ARLA PROTINO
Experimental: Individualized Physical Exercise Training with Protein Supl.
This group is also called EXER group, and will receive individually tailored physical exercise programs, based on their strength and weaknesses from the baseline testing.
Besides getting prescribed individualized physical exercise training programs, this group will consume protein supplementation (ARLA PROTINO) in form of protein enriched yogurts for easy consumption, two times daily, with each bottle containing 14 g of protein.
Other Names:
  • ARLA PROTINO

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short Musculoskeletal Function Assessment (SMFA) - Dysfunction Index
Time Frame: Change from: baseline to 3 months (primary endpoint) and 12 months
Self reported
Change from: baseline to 3 months (primary endpoint) and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean change from baseline in mobility with The New Mobility Score
Time Frame: Change from: baseline to 3 months and 12 months
The New Mobility Score assesses the patient's walking function inside, outside, and during shopping. Including whether a walking aid is used. The NMS provides a composed score of the participants' mobility. Each question is scored between 0-3 points, depending on the degree of help. The total possible score is between 0 and 9 points.
Change from: baseline to 3 months and 12 months
Mean change from baseline in the PRISMA-7 score
Time Frame: Change from: baseline to 3 months and 12 months
The PRISMA-7 questionnaire is composed of seven items and is used to indicate frailty among participants - each question scores either 0 or 1 points. The total possible score is between 0 and 7 points.
Change from: baseline to 3 months and 12 months
Mean change from baseline in the Tilburg Frailty Scale score
Time Frame: Change from: baseline to 3 months and 12 months

The Tilburg Frailty Scale is a questionnaire with a bio-psycho-social approach, which measures frailty. It is composed of 15 multidimensional questions, regarding the physical, psychological, and social aspects of human functioning.

Scoring range is between 0-15 points.

Change from: baseline to 3 months and 12 months
Mean change from baseline in health-related quality of life on SF-36
Time Frame: Change from: baseline to 3 months and 12 months
The SF-36 is a generic questionnaire that measures health-related quality of life in the past four weeks. The questionnaire consists of 36 questions which are divided into eight sub-scales and summarized in 2 sum scores.
Change from: baseline to 3 months and 12 months
Measure of pain, physical activity level and educational level
Time Frame: Change from: baseline to 3 months and 12 months
A survey with self-formulated questions regarding name, sex, personal ID (CPR number), educational level, the region of pain the last three months (marked on a body chart), pain intensity at the site of pain, and physical activity level will also be collected.
Change from: baseline to 3 months and 12 months
Mean change from baseline in weight
Time Frame: Change from: baseline to 3 months and 12 months
Weight (in kilograms). Weight and height will be combined to report BMI in kg/m^2.
Change from: baseline to 3 months and 12 months
Measure of height at baseline
Time Frame: Baseline
Height (in meters). Weight and height will be combined to report BMI in kg/m^2.
Baseline
Mean change from baseline in blood pressure
Time Frame: Change from: baseline to 3 months and 12 months
Systolic and diastolic blood pressure (mmHg) will be measured using the Omron HBP 1100 blood pressure and resting heart rate monitor.
Change from: baseline to 3 months and 12 months
Mean change from baseline in resting heart rate
Time Frame: Change from: baseline to 3 months and 12 months
Resting heart rate (in beats per minute) will be measured using the Omron HBP 1100 blood pressure and resting heart rate monitor.
Change from: baseline to 3 months and 12 months
Mean change from baseline in body composition measured with a bioimpedance device
Time Frame: Change from: baseline to 3 months and 12 months

The electrical bioimpedance device used in the present study to measure changes in body composition is the "Tanita 9MC-780U Multi Frequency Segmental Body Composition Analyzer".

Lean body mass (in kilograms), fat percentage (described as a percentage of the total body mass), total body water (described as a percentage of the total body mass), a visceral fat indicator will be reported

Change from: baseline to 3 months and 12 months
Mean change from baseline in the basic metabolic rate (BMR)
Time Frame: Change from: baseline to 3 months and 12 months
BMR will be estimated by a bioelectrical impedance analysis device "Tanita 9MC-780U Multi Frequency Segmental Body Composition Analyze".
Change from: baseline to 3 months and 12 months
Mean change from baseline of Waist-To-Hip ratio
Time Frame: Change from: baseline to 3 months and 12 months
The circumference of the waist (in centimeters) will be divided with the circumference of the hip (in centimeters) to report the Waist-to-hip ratio.
Change from: baseline to 3 months and 12 months
Mean change from baseline in maximal isometric voluntary contraction of leg extension
Time Frame: Change from: baseline to 3 months and 12 months
A maximal isometric voluntary contraction (in newtons) for knee extension will be performed using a strain gauge.
Change from: baseline to 3 months and 12 months
Mean change from baseline in handgrip strength
Time Frame: Change from: baseline to 3 months and 12 months
The handgrip strength (in kilograms) will be measured using a hydraulic handgrip dynamometer (SAEHAN).
Change from: baseline to 3 months and 12 months
Mean change from baseline in leg press strength
Time Frame: Change from: baseline to 3 months and 12 months
Five repetitions maximum (RM) strength tests will be performed in the leg press (in kilograms) to calculate 1 RM.
Change from: baseline to 3 months and 12 months
Mean change from baseline in knee extension strength
Time Frame: Change from: baseline to 3 months and 12 months
Five repetitions maximum (RM) strength tests will be performed in knee extension (in kilograms) to calculate 1 RM.
Change from: baseline to 3 months and 12 months
Mean change from baseline in calf extension strength
Time Frame: Change from: baseline to 3 months and 12 months
Five repetitions maximum (RM) strength tests will be performed in the calf extension (in kilograms) to calculate 1 RM.
Change from: baseline to 3 months and 12 months
Mean change from baseline in function measured with the 2 minutes walk test (2MWT)
Time Frame: Change from: baseline to 3 months and 12 months
The 2MWT will measure the distance (in meters) a person can walk in 2 minutes. Gaits speed will be calculated by dividing the covered distance with the time (120 seconds).
Change from: baseline to 3 months and 12 months
Mean change from baseline in heart rate during 2 minutes walk test (2MWT)
Time Frame: Change from: baseline to 3 months and 12 months
Heart rate (in BPM) will be measured (using the Apple Watch serie 5) before and right after the 2MWT.
Change from: baseline to 3 months and 12 months
Mean change from baseline in heart rate before and after the 2 minutes walk test (2MWT)
Time Frame: Change from: baseline to 3 months and 12 months
Heart rate (in BPM) will be measured (using the Apple Watch serie 5) before and right after the 2MWT.
Change from: baseline to 3 months and 12 months
Mean change from baseline in The Borg Rating of Perceived Exertion before and after the 2 minutes walk test (2MWT)
Time Frame: Change from: baseline to 3 months and 12 months
The Borg Rating of Perceived Exertion will be used to estimate the activity intensity before and right after the 2MWT.
Change from: baseline to 3 months and 12 months
Mean change from baseline in function measured with the Timed Up and Go test (TUG)
Time Frame: Change from: baseline to 3 months and 12 months
Time is noted (in seconds) on how long it takes to get up from a chair, walk 3 meters, turn around and go back to the chair and sit down again.
Change from: baseline to 3 months and 12 months
Mean change from baseline in balance measured with the Tandem test
Time Frame: Change from: baseline to 3 months and 12 months
A measure of static balance will be performed using a Tandem test. The participants will be tested in three positions for 10 seconds each (feet together, semi tandem and full tandem). Time is noted (in seconds) for how long the participant can stand in each position.
Change from: baseline to 3 months and 12 months
Balance and reaction time for upper and lower extremity
Time Frame: Change from: baseline to 3 months and 12 months
Measures for balance and reaction time will be collected using the "Fysiometer," and the protocols within the "Fysiometer" software will be followed.
Change from: baseline to 3 months and 12 months
Protein and energy intake
Time Frame: Change from: baseline, week 3, week 6, week 9, 3 months and 12 months
During the 12-week intervention period, protein and energy intake will be estimated based on the average of four 24-hour dietary recall interviews, either by home visits or by phone. Dietary interviews will also be conducted at 12 month follow-up.
Change from: baseline, week 3, week 6, week 9, 3 months and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sanel Teljigovic, PhD student, University College Absalon & University of Southern Denmark

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 10, 2020

Primary Completion (Actual)

June 1, 2023

Study Completion (Actual)

June 1, 2023

Study Registration Dates

First Submitted

September 4, 2019

First Submitted That Met QC Criteria

September 13, 2019

First Posted (Actual)

September 16, 2019

Study Record Updates

Last Update Posted (Actual)

June 23, 2023

Last Update Submitted That Met QC Criteria

June 22, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 8045-00052B (Danish Council for Independent Research)
  • SJ-758 (Other Identifier: Ethics Committee, Region Zealand, Denmark)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data collected during the project period will be sent to "The Danish National Archives" https://www.sa.dk/en/

IPD Sharing Time Frame

Data will be available immediately after it is submitted to the Danish National Archives.

IPD Sharing Access Criteria

Data is managed by the Danish National Archives and can be disclosed according to the Danish "notes of archive act / LBK no. 1201 from 28/09/2016".

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rehabilitation

Clinical Trials on Usual Care

3
Subscribe